| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Sep 24 | Dec 23 | Dec 22 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 9 |
| Opened positions | 9 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 260.72 mm |
| Total shares | 68.07 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| CTXR Citius Pharmaceuticals | 66.05 mm | $211.36 mm |
| 10XYZ | 1.98 mm | $6.33 mm |
| Yakira Capital Management | 15.50 k | $21.54 mm |
| Virtu Financial | 10.29 k | $14.00 k |
| IFP Advisors | 8.14 k | $11.31 mm |
| Advisor | 5.48 k | $7.62 mm |
| UBS UBS | 1.63 k | $2.27 mm |
| BAC Bank of America | 160.00 | $222.00 k |
| Tower Research Capital | 41.00 | $57.00 k |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Dec 24 | Dutia Suren G | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 125,000 | 133.75 k | 125,000 |
| 12 Dec 24 | Myron Czuczman | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 400,000 | 428.00 k | 400,000 |
| 12 Dec 24 | Mazur Leonard L | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 800,000 | 856.00 k | 800,000 |
| 12 Dec 24 | Webb Carol | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 125,000 | 133.75 k | 125,000 |
| 12 Dec 24 | Holuka Eugene Myron | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 125,000 | 133.75 k | 125,000 |
